Ofloxacin
Oflodinex is a medicinal product in the form of eye drops intended for the treatment of superficial eye infections, such as:
Ofloxacin belongs to a group of medicines called quinolone antibacterials.
Before starting treatment with Oflodinex, discuss with your doctor or pharmacist:
Caution should be exercised when using the medicinal product in patients with damaged or ulcerated eye surface.
As with other antibiotics, prolonged use of Oflodinex may lead to the growth of non-susceptible microorganisms. If such an infection occurs during treatment, the doctor will take appropriate measures.
Tendinitis and tendon rupture have occurred in patients taking fluoroquinolones orally or intravenously, especially in older patients and those treated with corticosteroids at the same time. Treatment with Oflodinex should be discontinued if pain or tenderness of the tendon (tendinitis) occurs.
There is limited experience with the use of ofloxacin eye drops in children.
Before using the medicinal product in children, consult a doctor.
Tell your doctor about all medicines you are taking or have recently taken, as well as medicines you plan to take.
In case of concomitant use of other eye drops and/or eye ointments, maintain an interval of at least 15 minutes between administration of the individual medicinal products. Eye ointments should always be used last.
Inform your doctor if you are pregnant or breastfeeding. The doctor will advise you whether you can use this medicinal product.
Using Oflodinex may cause blurred vision. These symptoms may persist for a few minutes. During this time, do not operate machines, work without strong support, or drive vehicles.
The medicinal product contains 0.025 mg of benzalkonium chloride per ml.
Benzalkonium chloride may be absorbed by soft contact lenses and change their color. Remove contact lenses before instillation and wait at least 15 minutes before reinserting.
Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or corneal disorders (the transparent layer at the front of the eye). If you experience any abnormal sensations in the eye, stinging, or eye pain after using the medicinal product, consult a doctor.
Using contact lenses during eye infection treatment is not recommended.
This medicinal product should always be used exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
For patients in all age groups, the recommended dose is:
1 dropof Oflodinex
In case of worsening of the infection or lack of improvement after a few days, consult a doctor.
Do not use the medicinal product for more than 14 days.
No cases of overdose have been reported to date. In case of accidental instillation of too many drops into the eye (eyes), rinse the eye with clean water.
In case of systemic side effects after incorrect use of the medicinal product or accidental overdose or ingestion, initiate systemic treatment. In this case, consult a doctor.
Do not use a double dose to make up for a missed dose. Use the next dose as soon as you remember. Then use the medicinal product as described in the dosing schedule above or as advised by your doctor.
If you have any further questions on the use of this medicinal product, ask your doctor or pharmacist.
Like all medicines, this medicinal product can cause side effects, although not everybody gets them.
Frequency not known (cannot be estimated from the available data):
During treatment with ofloxacin eye drops, life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported, initially appearing as red, often itchy patches or blisters on the trunk, sometimes with blisters in the mouth.
In case of an allergic reaction (including eye allergic reactions), discontinue use of the eye drops and consult a doctor immediately. The frequency of this side effect is not known (cannot be estimated from the available data).
The following side effects have been reported:
Very rare (less than 1 in 10,000 people):
Frequency not known (cannot be estimated from the available data):
If you experience any side effects, including any not listed in this leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicinal product.
Keep the medicinal product out of the sight and reach of children.
Do not use this medicinal product after the expiry date stated on the label and carton. The expiry date refers to the last day of the month.
The inscription on the packaging after the abbreviation EXP means the expiry date, and after the abbreviation Lot means the batch number.
Shelf life after first opening: 4 weeks.
Do not store above 25°C. Do not store in the refrigerator or freeze.
Keep the bottle in the outer packaging to protect it from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Oflodinex eye drops are a clear, greenish-yellow solution.
The package contains 1 LDPE container with a dropper cap, containing 5 ml of eye drops, or 3 containers with a dropper cap, each containing 5 ml of eye drops.
Not all pack sizes may be marketed.
Marketing Authorization Holder
Zakłady Farmaceutyczne POLPHARMA S.A.
ul. Pelplińska 19
83-200 Starogard Gdański
tel. +48 22 364 61 01
Manufacturer
Pharma Stulln GmbH
Werksstrasse 3
92551 Stulln, Germany
Date of Last Revision of the Package Leaflet:
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.